235 related articles for article (PubMed ID: 28150872)
21. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.
Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A
Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and Cervical Cancer Cells.
Naemura M; Murasaki C; Inoue Y; Okamoto H; Kotake Y
Anticancer Res; 2015 Oct; 35(10):5377-82. PubMed ID: 26408699
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial.
Moreau P; Facon T; Attal M; Hulin C; Michallet M; Maloisel F; Sotto JJ; Guilhot F; Marit G; Doyen C; Jaubert J; Fuzibet JG; François S; Benboubker L; Monconduit M; Voillat L; Macro M; Berthou C; Dorvaux V; Pignon B; Rio B; Matthes T; Casassus P; Caillot D; Najman N; Grosbois B; Bataille R; Harousseau JL;
Blood; 2002 Feb; 99(3):731-5. PubMed ID: 11806971
[TBL] [Abstract][Full Text] [Related]
24. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
25. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Cook G; Ashcroft AJ; Cairns DA; Williams CD; Brown JM; Cavenagh JD; Snowden JA; Parrish C; Yong K; Cavet J; Hunter H; Bird JM; Pratt G; Chown S; Heartin E; O'Connor S; Drayson MT; Hockaday A; Morris TC;
Lancet Haematol; 2016 Jul; 3(7):e340-51. PubMed ID: 27374467
[TBL] [Abstract][Full Text] [Related]
26. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia.
Iacobucci I; Sazzini M; Garagnani P; Ferrari A; Boattini A; Lonetti A; Papayannidis C; Mantovani V; Marasco E; Ottaviani E; Soverini S; Girelli D; Luiselli D; Vignetti M; Baccarani M; Martinelli G
Leuk Res; 2011 Aug; 35(8):1052-9. PubMed ID: 21414664
[TBL] [Abstract][Full Text] [Related]
27. Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer.
Liu B; Shen ED; Liao MM; Hu YB; Wu K; Yang P; Zhou L; Chen WD
Tumour Biol; 2016 Jul; 37(7):9875-86. PubMed ID: 26812694
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
[TBL] [Abstract][Full Text] [Related]
29. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.
Cunnington MS; Santibanez Koref M; Mayosi BM; Burn J; Keavney B
PLoS Genet; 2010 Apr; 6(4):e1000899. PubMed ID: 20386740
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
Yin Y; Yang W; Zhang L; Liu K; Luo Z
Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
[TBL] [Abstract][Full Text] [Related]
31. Genetic and epigenetic associations of ANRIL with coronary artery disease and risk factors.
Xu B; Xu Z; Chen Y; Lu N; Shu Z; Tan X
BMC Med Genomics; 2021 Oct; 14(1):240. PubMed ID: 34615528
[TBL] [Abstract][Full Text] [Related]
32. High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at All India Institute of Medical Sciences, New Delhi, using non-cryopreserved peripheral blood stem cells.
Kayal S; Sharma A; Iqbal S; Tejomurtula T; Cyriac SL; Raina V
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):140-7. PubMed ID: 24342104
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.
Chi JS; Li JZ; Jia JJ; Zhang T; Liu XM; Yi L
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):816-822. PubMed ID: 29270737
[TBL] [Abstract][Full Text] [Related]
34. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
35. Triple MEL100 therapy in multiple myeloma.
Berz D; Colvin GA; McCormack EM; Winer ES; Karwan P; Colvin L; Rathore R; Lum LG; Elfenbein GJ; Quesenberry PJ
Transplant Proc; 2009 Nov; 41(9):3863-7. PubMed ID: 19917402
[TBL] [Abstract][Full Text] [Related]
36. Melphalan 140 mg/m
Auner HW; Iacobelli S; Sbianchi G; Knol-Bout C; Blaise D; Russell NH; Apperley JF; Pohlreich D; Browne PV; Kobbe G; Isaksson C; Lenhoff S; Scheid C; Touzeau C; Jantunen E; Anagnostopoulos A; Yakoub-Agha I; Tanase A; Schaap N; Wiktor-Jedrzejczak W; Krejci M; Schönland SO; Morris C; Garderet L; Kröger N
Haematologica; 2018 Mar; 103(3):514-521. PubMed ID: 29217776
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA,
Matsunaga N; Wakasaki T; Yasumatsu R; Kotake Y
Anticancer Res; 2019 Aug; 39(8):4073-4077. PubMed ID: 31366490
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphisms in long noncoding RNA, ANRIL, are not associated with severe periodontitis but with adverse cardiovascular events among patients with cardiovascular disease.
Schulz S; Seitter L; Werdan K; Hofmann B; Schaller HG; Schlitt A; Reichert S
J Periodontal Res; 2018 Oct; 53(5):714-720. PubMed ID: 29732560
[TBL] [Abstract][Full Text] [Related]
39. High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial.
Vesole DH; Crowley JJ; Catchatourian R; Stiff PJ; Johnson DB; Cromer J; Salmon SE; Barlogie B
J Clin Oncol; 1999 Jul; 17(7):2173-9. PubMed ID: 10561273
[TBL] [Abstract][Full Text] [Related]
40. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
